WSJ
Search documents
Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts
WSJ· 2025-12-10 21:33
Core Insights - The software giant is making significant investments to establish itself as a leading cloud provider in the AI era [1] Group 1: Company Strategy - The company is heavily investing in cloud infrastructure to support its ambitions in artificial intelligence [1] - The focus on becoming a major player in the cloud market indicates a strategic shift towards AI-driven solutions [1] Group 2: Industry Implications - The move reflects a broader trend in the industry where companies are prioritizing cloud capabilities to leverage AI technologies [1] - Increased competition in the cloud sector is expected as more firms aim to capitalize on the growing demand for AI services [1]
Fed to Resume Net Asset Purchases With $40 Billion in Securities This Month
WSJ· 2025-12-10 19:21
Core Viewpoint - The Federal Reserve plans to expand its balance sheet by purchasing short-term Treasury securities to alleviate pressure in overnight lending markets, which are essential for the overall financial system [1] Group 1 - The Federal Reserve is ready to buy short-term Treasury securities [1] - The aim of this action is to prevent pressure in overnight lending markets [1] - Overnight lending markets are critical to the broader financial system [1]
The Fed cut rates but signaled reluctance to ease further. Three dissents underscored diverging views on the path forward.
WSJ· 2025-12-10 19:04
Three officials dissented in opposite directions. Stalled progress on inflation and a cooling job market made for one of the most divided meetings in years ...
U.S. Investors Are Going Big on China AI Despite Concerns in Congress
WSJ· 2025-12-10 17:00
Investors are plowing money into Chinese companies involved in AI despite growing competition between Washington and Beijing over the technology. ...
Investors Bet That a Higher Bid for Warner Bros. Is Coming
WSJ· 2025-12-10 16:41
Media company's shares surged Tuesday and Wednesday, with hedge funds hoping for Paramount, Netflix bidding war. ...
Instacart Shares Fall on Report Alleging Price Discrimination
WSJ· 2025-12-10 16:23
Core Insights - The grocery-delivery company's stock experienced a decline in morning trading due to a report indicating that it displayed varying prices for the same item added by users from the same store simultaneously [1] Company Summary - The grocery-delivery company is facing scrutiny as it was reported to show different prices for identical items added to the cart by users at the same time from the same store [1]
U.S. Crude-Oil Stockpiles Post Weekly Decline
WSJ· 2025-12-10 16:09
Core Insights - U.S. crude oil inventories decreased by 1.8 million barrels last week, indicating a tightening supply in the market [1] - Current inventories are approximately 4% lower than the five-year average for this time of year, suggesting potential upward pressure on oil prices [1]
YouTube TV to Offer Pared-Down, Lower-Priced Channel Bundles
WSJ· 2025-12-10 16:00
Core Insights - The new packages will enhance viewer customization options in the streaming industry, indicating a shift towards more personalized content delivery [1] Group 1 - The introduction of new packages adds to the already crowded streaming market, suggesting increased competition among providers [1]
Gov. Tiff Macklem says uncertainty remains elevated, and data volatility makes it difficult to judge underlying momentum
WSJ· 2025-12-10 15:00
Core Insights - Governor Tiff Macklem indicates that uncertainty remains elevated in the current economic environment, which complicates the assessment of underlying momentum [1] Group 1 - The volatility in data makes it challenging for the company to gauge the true economic momentum [1]
Roche Says Breast-Cancer Drug Shows Potential to Become Standard-Of-Care
WSJ· 2025-12-10 14:20
Core Insights - Giredestrant has demonstrated a 30% reduction in the risk of disease recurrence or death when compared to standard-of-care endocrine therapy according to the company [1] Company Summary - Giredestrant is positioned as a significant advancement in treatment options, showing improved efficacy over traditional therapies [1]